These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6763118

  • 1. [Methodologic aspects in psychopharmacology].
    Kaumeier HS.
    Methods Find Exp Clin Pharmacol; 1982; 4(7):539-42. PubMed ID: 6763118
    [Abstract] [Full Text] [Related]

  • 2. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C, Polard E, Mauduit N, Allain H.
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [Abstract] [Full Text] [Related]

  • 3. [The role of clinical psychiatry in the development of new drugs].
    Benkert O, Hippius H.
    Arzneimittelforschung; 1975 Jul; 25(7a):1195-206. PubMed ID: 1242348
    [Abstract] [Full Text] [Related]

  • 4. [Methodological and theoretical aspects of the evaluation of psychotropic drugs in normal healthy volunteers (author's transl)].
    Debus G.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):109-18. PubMed ID: 360235
    [Abstract] [Full Text] [Related]

  • 5. [Voluntary description of drug effects as a method in clinical trials. Presented using the example of pentobarbital, promazine and their combination].
    Kohnen R, Lienert GA.
    Arzneimittelforschung; 1979 May; 29(3):579-84. PubMed ID: 582749
    [Abstract] [Full Text] [Related]

  • 6. Planning of pharmacodynamic trials: I. Specificity and possible solutions. II. Stability considerations under placebo and interpretation of drug effects on EEG.
    Boeijinga PH, Calvi-Gries F, Demazières A, Luthringer R.
    Methods Find Exp Clin Pharmacol; 2002 May; 24 Suppl C():17-26. PubMed ID: 12575484
    [Abstract] [Full Text] [Related]

  • 7. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H, Müller-Oerlinghausen B.
    Arzneimittelforschung; 1974 Jul; 24(7):976-80. PubMed ID: 4603668
    [No Abstract] [Full Text] [Related]

  • 8. Current awareness in human psychopharmacology.
    Hum Psychopharmacol; 2005 Jul; 20(5):377-90. PubMed ID: 16114123
    [No Abstract] [Full Text] [Related]

  • 9. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
    Nobuhara K.
    Seishin Shinkeigaku Zasshi; 1993 Jul; 95(5):392-416. PubMed ID: 8356168
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A mixed crossover and parallel group design in psychopharmacological research--example B.
    Collins BE, Henker B, Whalen C.
    Psychopharmacol Bull; 1979 Jul; 15(3):40-2. PubMed ID: 493460
    [No Abstract] [Full Text] [Related]

  • 16. Towards a clinical methodology for neuropsychopharmacological research.
    Ban TA.
    Neuropsychopharmacol Hung; 2007 Jun; 9(2):81-90. PubMed ID: 17970531
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Directive principles for trials of cerebrally-acting drugs to be performed by groups of general practitioners].
    Hugonot L, Israël L, Hugonot R.
    Presse Med; 1983 Dec 29; 12(48):3147-9. PubMed ID: 6228930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.